Daiichi Sankyo Ownership
| DSKYF Stock | USD 24.00 1.30 5.73% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Daiichi |
Daiichi Pink Sheet Ownership Analysis
About 56.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 30th of March 2023. Daiichi Sankyo had 3:1 split on the 29th of September 2020. Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company was founded in 1899 and is headquartered in Tokyo, Japan. Daiichi Sankyo operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 16458 people.The quote for Daiichi Sankyo is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Daiichi Sankyo call the company at 81 3 6225 1111 or check out https://www.daiichisankyo.com.Currently Active Assets on Macroaxis
Other Information on Investing in Daiichi Pink Sheet
Daiichi Sankyo financial ratios help investors to determine whether Daiichi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Daiichi with respect to the benefits of owning Daiichi Sankyo security.